Diabetes and Metabolic Care: questions and answers

In detail

The assessment follows a structured approach. Your doctor reviews fasting and post-meal glucose readings, HbA1c trends, and any symptoms such as frequent urination, thirst, or fatigue. Blood tests evaluate renal function, electrolytes, and cholesterol. A foot examination checks pulses, sensation, and skin integrity.

Retinal screening is arranged annually. Evidence shows that regular complication screening reduces long-term morbidity. The team also reviews your medication list for dose adjustments and side effects. Lifestyle factors including diet, activity, sleep, and stress are discussed to build an individualised plan.

In detail

Type 2 diabetes symptoms tend to appear gradually. High blood glucose causes osmotic diuresis leading to thirst and frequent urination. Inadequate glucose utilisation causes fatigue and weight loss despite normal or increased appetite.

Chronic hyperglycaemia damages small vessels, resulting in blurred vision, poor wound healing, and nerve symptoms like numbness or tingling. Females may experience frequent vaginal yeast infections and urinary tract infections. Evidence shows that early developmental factors, genetics, and lifestyle all contribute to risk.

If you have a family history, obesity, sedentary habits, or belong to a high-risk ethnic group, you should be screened even without symptoms. The lifetime risk is 40 percent with one affected parent and 70 percent with both.

In detail

Acute metabolic emergencies develop when insulin deficiency or severe insulin resistance prevents glucose utilisation. In diabetic ketoacidosis, the body breaks down fat, producing ketones that acidify the blood. Symptoms include nausea, vomiting, abdominal pain, Kussmaul breathing, and altered mental status.

Hyperosmolar hyperglycaemic state presents with extreme hyperglycaemia, severe dehydration, and confusion without significant ketosis. Severe hypoglycaemia below 70 mg/dL can cause seizures or unconsciousness if untreated. Evidence shows that delayed treatment increases mortality risk.

The 24-hour emergency department at Jaipur Hospital manages these crises with intravenous fluids, insulin infusion, and electrolyte correction. Any patient on insulin or SGLT2 inhibitors who develops vomiting, abdominal pain, or altered sensorium should attend emergency without delay.

In detail

Test selection follows a risk-stratified approach. Newly diagnosed patients receive a broader baseline panel including autoantibodies if type 1 diabetes is suspected. Patients on metformin long-term need vitamin B12 monitoring. Those on SGLT2 inhibitors require renal function and ketone checks during illness.

Insulin users need more frequent glucose profiling, sometimes via continuous glucose monitoring for 7 to 14 days. Evidence supports individualised testing intervals rather than fixed schedules for all. The doctor also considers your age, comorbidities, and previous results.

For example, if microalbuminuria was normal last year, it may be repeated annually; if abnormal, it is checked more often. The in-house laboratory provides same-day results for most routine tests.

In detail

The care plan is dynamic. If HbA1c remains above target despite maximal oral therapy, guidelines support adding a GLP-1 agonist or basal insulin. If renal function falls below 45 mL/min, metformin dose is reduced and SGLT2 inhibitors may be stopped.

Lipid results above goal initiate or intensify statin therapy. Blood pressure above 130/80 mmHg prompts antihypertensive adjustment, often with ACE inhibitors or ARBs for renal protection. Evidence shows that early intervention on each abnormal parameter reduces cardiovascular events.

Continuous glucose monitoring data can reveal nocturnal hypoglycaemia or post-meal spikes, leading to insulin timing changes. The doctor explains each change and sets new targets at the follow-up visit.

In detail

Choice depends on individual factors. Metformin remains the foundation unless contraindicated by renal impairment. SGLT2 inhibitors and GLP-1 agonists are preferred when cardiovascular or renal protection is needed, or weight loss is a goal. DPP-4 inhibitors offer neutral weight effect and low hypoglycaemia risk.

Insulin is started when HbA1c is very high, symptoms are marked, or oral agents fail. Basal-bolus or premixed regimens are taught with self-monitoring education. Evidence supports individualised selection rather than a fixed algorithm.

The team also provides medical nutrition therapy, which can reduce HbA1c by 0.3 to 2.0 percent, and structured exercise guidance targeting 150 minutes weekly. Continuous glucose monitoring for 7 to 14 days helps fine-tune any regimen.

In detail

Observation with lifestyle intervention is appropriate for prediabetes or newly diagnosed type 2 diabetes with HbA1c near target. Evidence shows medical nutrition therapy reduces HbA1c by 0.3 to 2.0 percent and exercise lowers it by an average of 0.66 percent over eight weeks.

Medicines are introduced when lifestyle alone is insufficient, following a stepwise approach. Rehabilitation addresses diabetic neuropathy, foot ulcers, and deconditioning. Physiotherapy improves balance, strength, and gait, reducing fall risk. Foot care education prevents ulcers. Cardiac rehabilitation may be advised after cardiovascular events.

The team coordinates these components so they reinforce each other. For example, exercise prescription considers medication timing to avoid hypoglycaemia.

In detail

Medical management is the primary treatment for diabetes. Surgery addresses complications. Infected or ischaemic foot ulcers may need surgical debridement, revascularisation, or amputation to prevent sepsis. Proliferative diabetic retinopathy may require laser photocoagulation or vitrectomy. End-stage renal disease needs dialysis access creation or transplant evaluation.

Evidence shows bariatric surgery can lead to diabetes remission in some patients with obesity, but it is not first-line and requires multidisciplinary assessment. The decision involves surgeons, endocrinologists, and the patient. Your diabetes team coordinates referrals when a procedural intervention is indicated.

In detail

Lifestyle changes and oral medicines such as Metformin, SGLT2 inhibitors, or GLP-1 agonists usually lower fasting and post-meal glucose within one to two weeks. Insulin titration may show daily changes as doses are adjusted.

Continuous glucose monitoring helps the team see patterns and modify therapy quickly. Evidence shows medical nutrition therapy can reduce HbA1c by 0.3 to 2.0 percent and regular exercise can lower HbA1c by about 0.66 percent over eight weeks or more. Individual response varies based on weight, age, other illnesses, and medication adherence.

In detail

Persistently high glucose can lead to acute problems like hyperosmolar hyperglycaemic state, which is life-threatening, or long-term damage to eyes, kidneys, nerves, and heart. Evidence shows cardiovascular complications are the leading cause of morbidity and mortality in type 2 diabetes.

Worsening symptoms may mean medication doses need adjustment, a new medicine is required, or an infection or other illness is raising glucose. The care team will review your home readings, check for ketones if needed, and modify the plan. Early action prevents hospitalisation.

In detail

Evidence shows regular physical activity improves glucose uptake and insulin sensitivity, but exercise can also cause hypoglycaemia if you take insulin or certain tablets.

Guidelines recommend at least 150 minutes of moderate exercise weekly, spread over three or more days, with no more than two consecutive days without activity. For travel, carry medicines, snacks, a glucose meter, and a doctor's letter for security checks. Adjust doses for time-zone changes.

At work, keep a hypo kit nearby and inform a colleague. Complications such as retinopathy or neuropathy may require modified activities; the team will advise specific precautions.

In detail

A fasting glucose of 70 to 99 mg/dL is considered healthy; 100 to 125 mg/dL suggests prediabetes; 126 mg/dL or higher on two occasions indicates diabetes.

Post-meal glucose is usually checked two hours after eating; values below 140 mg/dL are normal, 140 to 199 mg/dL suggest impaired glucose tolerance, and 200 mg/dL or higher supports a diabetes diagnosis.

HbA1c below 5.7 percent is normal, 5.7 to 6.4 percent is prediabetes, and 6.5 percent or above confirms diabetes. These three tests together show daily variability and long-term control. The team uses them to decide on lifestyle steps, oral medicines, or insulin, and to set personalised targets.

In detail

General guidance often suggests fasting glucose of 80 to 130 mg/dL, post-meal glucose below 180 mg/dL, and HbA1c under 7 percent for many adults.

However, older adults, those with frequent hypoglycaemia, advanced complications, or limited life expectancy may have higher targets such as HbA1c below 8 percent to avoid dangerous lows. Younger, newly diagnosed patients without heart disease may aim for HbA1c closer to 6.5 percent if achievable safely.

The team considers your daily routine, medication type, and monitoring method when agreeing on targets. Evidence shows early intensive control reduces long-term cardiovascular and microvascular complications, but the benefit must outweigh the risk of hypoglycaemia for each person.

In detail

If you are on insulin, especially basal-bolus regimens, you may need to check before each meal, at bedtime, and sometimes at 3 am to detect nocturnal hypoglycaemia.

On oral medicines with stable control, checking fasting and post-meal values two to three times a week may be enough. During illness, dose changes, travel, or pregnancy, frequency increases.

Continuous glucose monitoring sensors worn for seven to fourteen days provide a complete profile without finger pricks and are useful when starting or changing therapy.

Evidence shows regular self-monitoring helps you see the effect of food, activity, and medication, leading to better decisions and lower HbA1c over time.

In detail

Symptoms vary; some people feel shaky or anxious, others get irritable, confused, or drowsy. Night-time lows may cause sweating, nightmares, or morning headache. If you take insulin or insulin secretagogues, risk is higher, especially after missed meals, extra exercise, or alcohol.

Evidence shows patients with autonomic neuropathy or on insulin are at greater risk of exercise-induced hypoglycaemia. Always carry glucose tablets, sugar packets, or juice. If you become unable to swallow, a family member should give glucagon if prescribed and call for help.

After recovery, eat a snack with carbohydrate and protein. The team reviews every episode to adjust doses or timing and prevent recurrence.

In detail

Evidence shows many people live with undiagnosed diabetes for years; one study found nearly 24 percent of adults with diabetes were unaware. Having one parent with type 2 diabetes gives a 40 percent lifetime risk; both parents raises it to 70 percent.

South Asians develop diabetes at lower body weight and younger age. Early detection allows lifestyle intervention that can prevent or delay onset — studies show weight loss, healthy diet, and regular activity reduce risk significantly.

If you already have a diagnosis but feel your control is slipping, or if you are unsure about medication, diet, or monitoring, a review helps reset targets and prevent complications. The team uses fasting glucose, post-meal glucose, and HbA1c to confirm diagnosis and stage the condition.

• Evidence shows many people live with undiagnosed diabetes for years; one study found nearly 24 percent of adults with diabetes were unaware.

In detail

Type 1 diabetes is an autoimmune condition where the pancreas produces little or no insulin. It requires lifelong insulin therapy, regular glucose monitoring, and education on dose adjustment.

Evidence shows that early diagnosis and structured insulin initiation reduce the risk of acute complications such as diabetic ketoacidosis. Our team provides insulin therapy initiation and titration using basal-bolus or premixed regimens with self-monitoring education.

Continuous glucose monitoring sensors are available for 7 to 14 day profiling to adjust therapy. Annual complication screening covers retinal, renal, neuropathy, and vascular assessments.

In detail

Prediabetes means blood glucose is higher than normal but not yet in the diabetes range. Evidence shows that lifestyle changes can prevent or delay progression to type 2 diabetes.

Studies report that medical nutrition therapy reduces HbA1c by 0.3% to 2.0% in type 2 diabetes, and exercise interventions of at least 8 weeks lower HbA1c by an average of 0.66%.

Our team emphasises individualised nutrition plans with non-starchy vegetables, whole grains, lean protein, and healthy fats. Current guidelines suggest at least 150 minutes of moderate to vigorous exercise per week spread over at least three days. Weight loss of 5% to 10% of body weight improves insulin sensitivity significantly.

In detail

Insulin is started when the pancreas can no longer produce enough insulin to keep glucose in range. Evidence shows that early glycaemic intervention prevents complications and reduces cardiovascular endpoints.

Our team uses structured titration protocols with home glucose monitoring or continuous glucose monitoring sensors worn for 7 to 14 days. The choice of regimen depends on your lifestyle, meal pattern, and glucose profile.

Education covers injection technique, dose adjustment for meals and activity, and hypoglycaemia recognition and treatment. Regular review ensures doses match changing needs.

In detail

Continuous glucose monitoring uses a small sensor worn on the arm or abdomen that reads interstitial glucose every few minutes. Evidence shows it helps identify patterns missed by finger-prick tests, such as nocturnal hypoglycaemia or post-meal spikes.

Studies report that CGM use improves HbA1c and reduces time in hypoglycaemia. Our team applies the sensor, reviews the 7 to 14 day profile, and adjusts medication, insulin doses, or meal timing accordingly.

It is especially useful for people on insulin, those with hypoglycaemia unawareness, or during pregnancy. The data also guides lifestyle counselling.

In detail

Diabetic neuropathy is nerve damage caused by prolonged high glucose. Evidence shows most patients with type 2 diabetes have at least one complication, and neuropathy is common. It increases the risk of foot ulcers, falls, and unnoticed injuries.

Our screening includes clinical examination of sensation, reflexes, and vascular status. If neuropathy is found, the team advises on foot care, footwear, glucose target optimisation, and pain management if needed.

Exercise guidance is tailored; for example, patients with nerve problems may need to limit walking that could cause blisters. Early detection and glucose control slow progression.

In detail

Evidence shows that insulin resistance is influenced by hormonal disorders, inflammation, and medication side effects. For example, glucocorticoids increase hepatic glucose output and reduce peripheral uptake. Antipsychotics like olanzapine and clozapine are linked to weight gain and metabolic syndrome.

Beta-blockers may blunt the sympathetic warning signs of hypoglycaemia. Thiazide diuretics can impair insulin secretion. Our team cross-checks your prescription list, orders relevant hormonal or renal tests if indicated, and coordinates with the prescribing specialists to adjust doses or switch agents where possible. This comprehensive review ensures your diabetes plan accounts for all contributing factors.

In detail

Evidence shows that cardiovascular disease is the leading cause of morbidity and mortality in type 2 diabetes. Patients with diabetic kidney disease need nephrology input for blood pressure targets, ACE inhibitor or ARB dosing, and preparation for renal replacement therapy.

Retinopathy screening requires ophthalmology for laser or anti-VEGF treatment. Neuropathy with foot ulcers may need vascular surgery and orthopaedics. Our multispeciality team communicates through shared records and case discussions.

This reduces duplication of tests and ensures that medication changes in one speciality do not conflict with another. Coordination is also important before major surgery, during pregnancy, and when starting medicines that affect glucose.

In detail

The consultation fee covers 20 to 30 minutes with the doctor, clinical assessment, prescription review, and lifestyle counselling.

The annual package is designed for ongoing management and typically includes four to six planned visits, quarterly HbA1c, annual lipid profile, renal function tests, urine microalbumin, retinal screening, neuropathy and vascular assessment.

Evidence supports regular monitoring: guidelines recommend HbA1c at least twice a year for stable patients and more often if therapy changes. Package pricing reflects these standard intervals. Costs for insulin, oral medicines, CGM sensors, and any specialist procedures are not included in the package.

Insurance coverage varies; RGHS, MAA Yojana, CGHS, and several private TPAs are accepted. The billing team can provide a detailed estimate before you commit.

In detail

The estimate covers the clinical consultation and standard lifestyle or medication review. Investigations such as blood tests (HbA1c, lipid profile, kidney function), urine tests, retinal screening, nerve conduction studies, or continuous glucose monitoring sensors are billed separately.

Medicines, insulin pens, needles, glucometer strips, and any specialist referrals for complications like cardiology or nephrology also carry separate charges. Hospitalisation for acute events like hyperosmolar hyperglycaemic state is not part of the outpatient estimate.